Mutations of PPP2R1A significantly enhance cancer cell migration in endometrial and ovarian carcinomas [40], whereas allosteric activation of this wild-type complex induces cell cycle arrest with broad anti-tumour activity [35]. This evidence concerns the gene PPP2R1A and cancer.